pbm glp-1 news Antagonists Increase Plan Drug Spend - What's Next BREAKING GLP1 NEWS 3/4/26: Slashed

Protein instability in poly(lactic-co-glycolic acid) microparticles

There are some gastrointestinal issues and a few serious side effects reported

Usually this means elevating your feet onto a stool, leaning forward slightly, and relaxing your belly

How Its Administered Subcutaneous (SubQ): Injected into belly fat or a fatty tissue area for systemic distribution Intramuscular (IM): Injected directly into or near an injured muscle or tendon for localized healing Dosage: Typically 250500 mcg daily, often split into two doses depending on severity Injectable BPC157 is typically sold as a lyophilized powder, reconstituted with bacteriostatic water and drawn into an insulin syringe for injection